The impact of cancer treatment on ovarian function and fertility has been known since the 70s. Preservation of fertility is now an important focus of care for patients of reproductive age with cancer. The beneficial role of GnRH agonists in fertility preservation is controversial since the early 2000s. Recent randomized studies come to overturn this role. The POEMS multicenter randomized trial with long-term follow-up is ongoing and will provide results that could help clarify the current uncertain indication of these compounds in this context.
Keywords: Agonistes de la GnRH; Cancer; Chemotherapy; Chimiothérapie; Fertility preservation; GnRH agonists; Préservation de la fertilité.
Copyright © 2013 Elsevier Masson SAS. All rights reserved.